Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract

Molecular Carcinogenesis

Volumn 52, Issue 6, 2013, Pages 438-445

  Wang, Wen Lun ^a,b   Chang, Wei Lun ^a   Yeh, Yi Chun ^a   Lee, Ching Tai ^b   Chang, Chi Yang ^b   Lin, Jaw Town ^b   Sheu, Bor Shyang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

Author keywords

Esophageal squamous cell carcinomas; Matrix metalloproteinase; Synchronous; Upper aero digestive tract

Indexed keywords

GELATINASE B; MATRILYSIN; STROMELYSIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 84876454392     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21874     Document Type: Article

References (35)

1. Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon (France): IARC Press; 2000. p. 270.
2. Taiwan Cancer Registry, Department of Health, Executive Yuan. 1972-2008. Cancer Registry Annual Report. Available at: http://crs.cph.ntu.edu.tw.
3. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multi-centric origin. Cancer 1953; 6: 963-968.
4. Haughey BH, Gates GA, Arfken CL, Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992; 101: 105-112.
5. Muto M, Hironaka S, Nakane M, Boku N, Ohtsu A, Yoshida S. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc 2002; 56: 517-521.
6. Wang WL, Lee CT, Lee YC, et al. Risk factors for developing synchronous esophageal neoplasia in patients with head and neck cancer. Head Neck 2011; 33: 77-81.
7. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor micro-environment. Cell 2010; 141: 52-67.
8. Li Y, Ma J, Guo Q, et al. Over-expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. Dis Esophagus 2009; 22: 664-667.
9. Hong DY, Lee BJ, Lee JC, Choi JS, Wang SG, Ro JH. Expression of VEGF, HGF, IL-6, IL-8, MMP-9, telomerase in peripheral blood of patients with head and neck squamous cell carcinoma. Clin Exp Otorhinolaryngol 2009; 2: 186-192.
10. Werner JA, Rathcke IO, Mandic R. The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 2002; 19: 275-282.
11. Ohashi K, Nemoto T, Nakamura K, Nemori R. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer 2000; 88: 2201-2209.
12. Shima I, Sasaguri Y, Kusukawa J, et al. Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. Br J Cancer 1993; 67: 721-727.
13. Gu ZD, Chen KN, Li M, Gu J, Li JY. Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma. World J Gastroenterol 2005; 11: 871-874.
14. Shima I, Sasaguri Y, Kusukawa J, et al. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinico-pathologic study. Cancer 1992; 70: 2747-2753.
15. Kurahara S, Shinohara M, Shirasuna K. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 1999; 21: 627-638.
16. Yamamoto H, Adachi Y, Itoh F, et al. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 1999; 59: 3313-3316.
17. Yamashita K, Mori M, Shiraishi T, Shibuta K, Sugimachi K. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin Cancer Res 2000; 6: 1169-1174.
18. Gu ZD, Li JY, Li M, et al. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. Am J Gastroenterol 2005; 100: 1835-1843.
19. Tanioka Y, Yoshida T, Yagawa T, et al. Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial esophageal cancer. Br J Cancer 2003; 89: 2116-2121.
20. Kusukawa J, Harada H, Shima I, Sasaguri Y, Kameyama T, Morimatsu M. The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity. Eur J Cancer B Oral Oncol 1996; 32B: 217-221.
21. Dünne AA, Sesterhenn A, Werner JA, Teymoortash A, Kuropkat C, Werner JA. Expression of MMP-2, -9 and -13 in cell lines and fresh biopsies of squamous cell carcinomas of the upper aerodigestive tract. Anticancer Res 2003; 23: 2233-2239.
22. O-Charoenrat P, Rhys-Evans PH, Eccles SA. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001; 127: 813-820.
23. Franchi A, Santucci M, Gallo O, Sardi I, Paglierani M, Gallo O. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 2002; 95: 1902-1910.
24. Greene FL, > Page DL, Fleming ID, et al. editors. American Joint Committee on Cancer. Cancer staging manual. 6th edition. New York: Springer; 2002. pp. 91-98.
25. Yeh YC, Sheu BS, Cheng HC, Wang YL, Yang HB, Wu JJ. Elevated serum matrix metalloproteinase-3 and -7 in H. pylori-related gastric cancer can be biomarkers correlating with a poor survival. Dig Dis Sci 2010; 55: 1649-1657.
26. Radisky DC, Levy DD, Littlepage LE, et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005; 436: 123-127.
27. Cowden Dahl KD, Symowicz J, Ning Y, et al. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res. 2008; 68: 4606-4613.
28. Dallas SL, Rosser JL, Mundy GR, Bonewald LF. Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J Biol Chem 2002; 277: 21352-21360.
29. Huang Y, Song N, Luo Y, et al. Pulmonary vascular destabilization in the pre-metastatic phase facilitates lung metastasis. Cancer Res 2009; 69: 7529-7537.
30. Kaplan RN, Riba RD, Rafii S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438: 820-827.
31. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109: 625-637.
32. Mroczko B, Kozłowski M, Szmitkowski M, et al. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients. Clin Chim Acta 2008; 389: 61-66.
33. Ruokolainen H, Pääkkö P, Turpeenniemi-Hujanen T. Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker. Int J Cancer 2005; 116: 422-427.
34. Łukaszewicz-Zajac M, Mroczko B, Szmitkowski M, Nikliński J, Laudański J, Szmitkowski M. Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma. Pol Arch Med Wewn 2009; 119: 558-563.
35. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer-trials and tribulations. Science 2002; 295: 2387-2392.